High levels of platelet/lymphocyte ratio are associated with metastatic gastric cancer

Journal of B.U.ON.

Volumn 20, Issue 1, 2015, Pages 78-83

  Cetinkunar, Suleyman ^a   Guzel, Hakan ^b   Gokce, Ismail Emre ^b   Erdem, Hasan ^a   Gulkan, Saygi ^c   Aktimur, Recep ^d   Kucuk, Bertan ^e   Imamoglu, Inane ^b   Kargici, Hulagu ^b  

^a Adana Numune Training and Research Hospital   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Social Security Institution   (Turkey)

^d SAMSUN TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e Melikgazi Hospital   (Turkey)

Author keywords

Gastric cancer; Metastasis; Platelet to lymphocyte ratio; Predictive value

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; EARLY CANCER; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PLATELET LYMPHOCYTE RATIO; STOMACH CANCER; TUMOR VOLUME; ADENOCARCINOMA; AREA UNDER THE CURVE; BLOOD; CARCINOMA, SIGNET RING CELL; CHI SQUARE DISTRIBUTION; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; STATISTICAL MODEL; STOMACH NEOPLASMS; THROMBOCYTE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; AREA UNDER CURVE; BLOOD PLATELETS; CARCINOMA, SIGNET RING CELL; CHI-SQUARE DISTRIBUTION; FEMALE; GASTRECTOMY; HUMANS; LOGISTIC MODELS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM STAGING; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84928705755     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: Cancer J Clin 2005;55:74-108.
2. Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006;24:2903-2909.
3. Salazar-Onfray F, Lopez MN, Mendoza-Naranjo A. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev 2007;18:171-182.
4. Alexandrakis MG, Passam FH, Moschandrea IA et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol 2003;26:135-140.
5. Lee S, Oh SY, Kim SH et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer 2013;13:350.
6. Feng J-F, Huang Y, Zhao Q, Chen Q-X. Clinical sig-nificance of preoperative neutrophil lymphocyte ratio versus platelet lymphocyte ratio in patients with small cell carcinoma of the esophagus. Sci World J 2013:2013:504365.
7. Krenn-Pilko S, Langsenlehner U, Thurner E-M et al. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer 2014;110:2524-2530.
8. Ozgehan G, Kahramanca S, Kaya IO et al. Neutro- phil-lymphocyte ratio as negative predictive factor for tumor staging in colorectal cancer. Turk J Med Sci 2014;44:365-368.
9. Pisani P, Parkin DM, Ferlay J. Estimates of the world-wide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993;55:891-903.
10. Asaka M, Kato M, Sakamoto N. Roadmap to eliminate gastric cancer with helicobacter pylori eradication and consecutive surveillance in Japan. J Gastroenterol 2014;49:1-8.
11. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003;362:305-315.
12. Aliustaoglu M, Bilici A, Ustaalioglu BBO et al. Theeffect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol 2010;27:1060-1065.
13. Buergy D, Wenz F, Groden C, Brockmann MA. Tumor-platelet interaction in solid tumors. Int J Cancer 2012;130:2747-2760.
14. Fogar P, Sperti C, Basso D et al. Decreased total lym-phocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas 2006;32:22-28.
15. Hussein MR, Ahmed RA. Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pre-tumorigenic and tumorigenic keratinocytic hy- perproliferative lesions of the skin. Cancer Biol Ther 2005;4:819-821.
16. Jaiswal M, LaRusso NF, Gores GJ. Nitric oxide in gas-trointestinal epithelial cell carcinogenesis: linking in-flammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 2001;281:G626-G634.
17. Kwon HC, Kim SH, Oh SY et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 2012;17:216-222.
18. Stone RL, Nick AM, McNeish IA et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 2012;366:610-618.
19. Wagner DD. New links between inflammation and thrombosis. Arterioscler Thromb Vase Biol 2005;25:1321-1324.
20. Ikeda M, Furukawa H, Imamura H et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002;9:287-291.
21. Bruckner HW, Lavin PT, Plaxe SC, Storch JA, Livstone EM. Absolute granulocyte, lymphocyte, and mono cyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach. JAMA 1982;247:1004-1006.
22. Jain S, Harris J, Ware J. Platelets: linking hemo- stasis and cancer. Arterioscler Thromb Vase Biol 2010;30:2362-2367.
23. Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999;59:1295-1300.
24. Menges T, Engel J, Welters I et al. Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med 1999;27:733-740.
25. Blake-Mortimer JS, Sephton SE, Carlson RW, Stites D, Spiegel D. Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer. Breast J 2004;10:195-199.
26. Fumagalli LA, Vinke J, Hoff W, Ypma E, Brivio F, Nespoli A. Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy. J Immunother 2003;26:394-402.
27. Matowicka-Karna J, Kamocki Z, Polinska B, Osada J, Kemona H. Platelets and inflammatory markers in patients with gastric cancer. Clin Dev Immunol 2013:2013:401623.
28. Wang D-s, Ren C, Qiu M-z et al. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol 2012;33:749-756.
29. Zhou X, Du Y, Huang Z et al. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One 2014;9(6):e101119.